Clinical Trial Update: Pembrolizumab in Early Stage Colon Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial of pembrolizumab for early-stage colon cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Chicago | Conditions: Colon Cancer | Phase 2 | Status: WITHDRAWN